Abingworth
Overview
Abingworth is an international investment group focused exclusively on the life sciences and healthcare sectors. The firm invests across all stages of company development including early and late-stage venture financing, growth equity and public companies. Founded in 1973, Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston. Must be healthcare or biotech related. Generally invests between $15M and $30M
Investment Focus
- Innovative therapeutics with potential to significantly improve human health
- Experienced management teams
- Companies at seed, early, or development stages
- Opportunities in biotechnology, pharmaceuticals, medical devices, and related sectors
Portfolio Companies
Reach Abingworth directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Abingworth
What sectors does Abingworth invest in?
Abingworth invests in Healthcare Services, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in London, England, United Kingdom. Abingworth is listed as a vc in the ConnectSafely investor database.
What stage does Abingworth invest at?
Abingworth backs companies at Seed and Early Stage, writing cheques of $10M - $50M.
Which regions does Abingworth invest in?
Abingworth invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Abingworth?
Team members listed for Abingworth include Neil Cooper (Chief Financial Officer).
What companies has Abingworth invested in?
Abingworth's portfolio includes Alnylam Pharmaceuticals, Gilead Sciences, IDEC Pharmaceuticals, Vera Therapeutics, Pharmion, Aurora Biosciences, Aviron and GelTex Pharmaceuticals.
How do I contact Abingworth?
Abingworth's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
